Identification of the anti-mycobacterial functional properties of piperidinol derivatives.
British Journal of Pharmacology, 174, 2183-2193
Tuberculosis (TB) remains a major global health threat and is now the leading cause of death from a single infectious agent worldwide. The current TB drug regimen is inadequate, and new anti-tubercular agents are urgently required to be able to successfully combat the increasing prevalence of drug-resistant TB. The purpose of this study was to investigate a piperidinol compound derivative that is highly active against the Mycobacterium tuberculosis bacillus.
British Journal of Pharmacology, 174, 2183-2193
View Publication

